Skip to main content
Fig. 1 | BMC Pharmacology and Toxicology

Fig. 1

From: Rosiglitazone increases endothelial cell migration and vascular permeability through Akt phosphorylation

Fig. 1

Effects of rosiglitazone or AKT inhibitor on body weight and blood glucose level. a Body weight in control, rosiglitazone, Akt inhibitor and rosiglitazone + Akt inhibitor groups. There was a tendency for body weight to increase with rosiglitazone treatment, but there was no statistically significant difference between the four groups (P = NS). b Blood glucose levels in four groups. There was a statistically significant decrease in blood glucose in the rosiglitazone group (*P < 0.05)

Back to article page
\